Latest News about Alethia Young
Recent news which mentions Alethia Young
Regeneron Requests Emergency Use Authorization, Analysts See Coronavirus Antibodies As Earnings Driver In 2021
October 08, 2020
From Benzinga
Why Regeneron's Growth Opportunity Is Unappreciated
October 05, 2020
From Benzinga
From Benzinga
5 ASCO Abstracts Moving Biopharma Stocks
May 14, 2020
From Benzinga
Gilead Analyst Sees Over 50% Chance Of Success For Remdesivir In Mild-To-Moderate COVID-19
April 07, 2020
From Benzinga
Gilead Analyst Sees Catalyst Ahead In Data Readout For Potential Coronavirus Treatment
April 06, 2020
Tickers
GILD
From Benzinga
Biogen's CTAD Presentation On Aducanumab Elicits Mixed Response
December 05, 2019
Tickers
BIIB
From Benzinga
From Benzinga
Viking Has A More Attractive M&A Valuation Than Madrigal, Raymond James Says In Upgrade
November 19, 2018
From Benzinga
From Benzinga
Credit Suisse: Celgene Needs To Win Back Investor Trust
February 28, 2018
Tickers
CELG
From Benzinga
Credit Suisse: Street Expectations 'Too High' For Gilead's Hep C Therapy
December 20, 2017
Tickers
GILD
From Benzinga
U.S. Approval Of PTC Therapeutics' Translarna 'Remains Unlikely'
September 29, 2017
From Benzinga
Credit Suisse Weighs In Ahead Of PTC Therapeutics' Thursday AdCom Panel For Translarna
September 26, 2017
From Benzinga
From Benzinga
Tickers
BIIB
From Business Journals
From Benzinga
From Benzinga
From Benzinga
Gilead Looking To Buy Incyte? It Makes Sense
March 14, 2017
From Benzinga
Stay Of Court Injunction A Mild Positive For Regeneron
February 09, 2017
From Benzinga
Credit Suisse Says Sarepta Shares Volatile, Still A Favorite Idea
January 05, 2017
From Benzinga
Biogen's Spinraza Could Cost $125,000 Per Dose
December 29, 2016
From Benzinga
Alexion Management On Internal Investigation: So Far, So Good
November 10, 2016
Tickers
ALXN
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.